Latest Selling Leads
.
| Date | Name/CAS No. | Suppliers/Manufactures | Check | ||
|---|---|---|---|---|---|
| 04-15 09:56 | Solitomab 1005198-65-1 |
||||
| 04-15 09:56 | Quilizumab 1228538-47-3 |
||||
| 04-15 09:56 | Patritumab 1262787-83-6 |
||||
| 04-15 09:56 | Onartuzumab 1133766-06-9 |
||||
| 04-15 09:56 | Ponezumab 1178862-65-1 |
||||
| 04-15 09:56 | Radretumab 1253180-81-2 |
||||
| 04-15 09:56 | Tregalizumab 1207446-68-1 |
||||
| 04-15 09:56 | Ublituximab 1174014-05-1 |
||||
| 04-15 09:56 | Vesencumab 1205533-60-3 |
||||
| 04-15 09:56 | Blosozumab 1132758-87-2 |
||||
| 04-15 09:56 | Crenezumab 1095207-05-8 |
||||
| 04-15 09:56 | Ozoralizumab 1167985-17-2 |
||||
| 04-15 09:56 | Oxelumab 1186098-83-8 |
||||
| 04-15 09:56 | Samalizumab 1073059-33-2 |
||||
| 04-15 09:56 | Atinumab 1226761-65-4 |
||||
| 04-15 09:56 | Lecanemab 1260393-98-3 |
||||
| 04-15 09:56 | Aducanumab 1384260-65-4 |
||||
| 04-15 09:56 | Tezepelumab 1572943-04-4 |
||||
| 04-15 09:56 | Benralizumab 1044511-01-4 |
||||
| 04-15 09:56 | Ocrelizumab 637334-45-3 |
